SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-011452
Filing Date
2023-04-19
Accepted
2023-04-19 16:30:15
Documents
2
Period of Report
2023-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1556
2 EX-24 DOCUMENT attachment1.htm EX-24 5820
  Complete submission text file 0000899243-23-011452.txt   8904
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Hofmeister Robert (Reporting) CIK: 0001760102 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33038 | Film No.: 23830370